Gandhinagar, India, is set to host over 950 infectious disease experts from India and abroad for CIDSCON 2026, the 16th annual conference of the Clinical Infectious Diseases Society. Scheduled from August 20 to 23 at the Mahatma Mandir Convention and Exhibition Centre, the event will place a significant emphasis on the role of artificial intelligence in clinical practice. This focus highlights a growing recognition of AI’s potential to transform how infectious diseases are diagnosed, prevented, and treated.
The conference will bring together a diverse group of professionals, including infectious disease specialists, clinicians, researchers, and microbiologists. Their collective goal is to share advancements and address challenges specific to India, particularly in areas like antimicrobial resistance and infection control. The integration of AI discussions reflects a forward-looking approach to healthcare innovation.
A key component of the program is a dedicated workshop titled “AI and Technology in ID Practice.” This session will delve into the current landscape of artificial intelligence, exploring applications that extend beyond large language models. Participants will engage in discussions about practical projects and problem-solving exercises, aiming to understand how AI can be effectively utilized in infectious disease management.
Exploring AI in Clinical Decision-Making
The specialized AI workshop offers an opportunity for healthcare professionals to explore the practical applications of AI. It will examine how AI tools could be integrated into infectious disease practice. A critical aspect of this discussion involves comparing AI’s capabilities with human clinical decision-making processes. This comparison seeks to clarify where AI can augment human expertise and where human judgment remains paramount.
Beyond the workshop, the main scientific program will also feature sessions on emerging technologies, including “AI-enabled clinical practice.” This indicates a broad interest in AI’s potential across various facets of infectious disease. Such discussions are crucial for understanding the future trajectory of medical technology.
Comprehensive Infectious Disease Agenda
While AI takes a prominent position, CIDSCON 2026 covers a wide range of essential topics. Antimicrobial resistance (AMR) is a central theme, with a special session on August 22 dedicated to strengthening AMR containment efforts in Gujarat. This session will review state initiatives, the Gujarat State AMR Surveillance Network (GUJSAR-N), and the monitoring of antimicrobial stewardship programs. It will also explore laboratory-data-based disease surveillance through an AMR dashboard.
Other critical areas of discussion include tropical infections, tuberculosis, HIV, fungal infections, and virology. Infection control and antimicrobial stewardship are also high on the agenda. The conference will address infections in immunocompromised patients, a complex and challenging aspect of clinical practice. These sessions aim to provide comprehensive updates and foster collaborative solutions.
Workshops and Expert Interactions
The conference begins on August 20 with a series of specialized workshops designed for hands-on learning and expert sessions. These include “ID 360: Mastering the Basics” and “Microbiology 360: Diagnostics, Stewardship and Infection Control.” Another workshop, “The Zero Defence Challenge: Mastering ID in the Immunocompromised,” addresses a specific clinical challenge. These interactive sessions will feature case-based discussions, enhancing practical knowledge for all attendees.
The event also facilitates interactions with national experts and international faculty from countries such as the United States and Singapore. These exchanges of knowledge and experience are vital for advancing global efforts against infectious diseases. The program includes challenging case discussions, award presentations, and poster rounds, alongside dedicated sessions for postgraduate students and fellows, fostering the next generation of specialists.
Health Minister Praful Pansheriya will inaugurate the conference and unveil a book on antimicrobial resistance and antimicrobial stewardship. This highlights the government’s commitment to addressing these critical public health issues. The convergence of diverse expertise and the focus on advanced technologies like AI underscore the conference’s ambition to drive significant progress in infectious disease management.
